logo
Select company
Select metric
$ -128.59MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
6
Sector
14
Industry
21
History
83
$ 2.19Close
$ 0.67 - $ 3.46 52-Week Range
Ticker Information

Ticker

GOSS

Company Name

GOSSAMER BIO INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

GOSSAMER BIO INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

GOSS - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 2.73M$ -131.32M$ -128.59M
3/31/2025$ 3.51M$ -39.21M$ -35.7M
12/31/2024$ 4.15M$ -44.12M$ -39.97M
9/30/2024$ 4.08M$ -56.33M$ -52.24M
6/30/2024$ 4.07M$ -63.79M$ -59.72M
3/31/2024$ 4.23M$ -159.44M$ -155.21M
12/31/2023$ 4.38M$ -166.31M$ -161.92M
9/30/2023$ 4.5M$ -173.7M$ -169.2M
6/30/2023$ 4.52M$ -192.93M$ -188.4M
3/31/2023$ 4.47M$ -206.84M$ -202.37M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • GOSSAMER BIO INC's latest trailing twelve months (TTM) EBITDA stands at $ -227.93M.
  • Over the past 5 years, GOSSAMER BIO INC's average EBITDA has been $ -167.3M.
  • The median EBITDA for GOSSAMER BIO INC during this period was $ -205.79M
  • GOSSAMER BIO INC reached its highest EBITDA over the past 5 years at $ -35.7M.
  • The lowest EBITDA recorded by GOSSAMER BIO INC in the same timeframe $ -227.93M

GOSSAMER BIO INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
XOMA : XOMA ROYALTY CORP $ -2.98MMGTX : MEIRAGTX HOLDINGS PLC $ -132.06MAUTL : AUTOLUS THERAPEUTICS PLC $ -227.48MALMS : ALUMIS INC $ -232.06MBCYC : BICYCLE THERAPEUTICS PLC $ -240.81MLXRX : LEXICON PHARMACEUTICALS INC $ -107.44MEDIT : EDITAS MEDICINE INC $ -235.43MFENC : FENNEC PHARMACEUTICALS INC $ -9.19MSCPH : SCPHARMACEUTICALS INC $ -85.42MEYPT : EYEPOINT PHARMACEUTICALS INC $ -173.27M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for GOSSAMER BIO INC is calculated as follows: EBIT [ $ -233.45M ] + DepAmor [ $ 5.52M ]
(=) EBITDA [ $ -227.93M ]

GOSS - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -227.93M

Minimum

Sep 30, 2020

$ -35.7M

Maximum

Mar 31, 2025

$ -167.3M

Average

$ -205.79M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.79M with a standard deviation of $ 166.94M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.25K
min$ -493.3M
max$ 590.6M
average$ 58.79M
median$ 8.83M
std$ 166.94M